1. Home
  2. SONM vs INTS Comparison

SONM vs INTS Comparison

Compare SONM & INTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SONM
  • INTS
  • Stock Information
  • Founded
  • SONM 1999
  • INTS 2012
  • Country
  • SONM United States
  • INTS United States
  • Employees
  • SONM N/A
  • INTS N/A
  • Industry
  • SONM Telecommunications Equipment
  • INTS Biotechnology: Pharmaceutical Preparations
  • Sector
  • SONM Telecommunications
  • INTS Health Care
  • Exchange
  • SONM Nasdaq
  • INTS Nasdaq
  • Market Cap
  • SONM 10.2M
  • INTS 9.4M
  • IPO Year
  • SONM 2019
  • INTS 2023
  • Fundamental
  • Price
  • SONM $1.49
  • INTS $0.32
  • Analyst Decision
  • SONM
  • INTS Strong Buy
  • Analyst Count
  • SONM 0
  • INTS 3
  • Target Price
  • SONM N/A
  • INTS $8.50
  • AVG Volume (30 Days)
  • SONM 11.6M
  • INTS 2.7M
  • Earning Date
  • SONM 08-08-2025
  • INTS 08-07-2025
  • Dividend Yield
  • SONM N/A
  • INTS N/A
  • EPS Growth
  • SONM N/A
  • INTS N/A
  • EPS
  • SONM N/A
  • INTS N/A
  • Revenue
  • SONM $58,243,000.00
  • INTS N/A
  • Revenue This Year
  • SONM $127.68
  • INTS N/A
  • Revenue Next Year
  • SONM N/A
  • INTS N/A
  • P/E Ratio
  • SONM N/A
  • INTS N/A
  • Revenue Growth
  • SONM N/A
  • INTS N/A
  • 52 Week Low
  • SONM $0.85
  • INTS $0.26
  • 52 Week High
  • SONM $10.50
  • INTS $5.10
  • Technical
  • Relative Strength Index (RSI)
  • SONM 59.58
  • INTS 37.08
  • Support Level
  • SONM $0.97
  • INTS $0.28
  • Resistance Level
  • SONM $2.08
  • INTS $0.32
  • Average True Range (ATR)
  • SONM 0.30
  • INTS 0.06
  • MACD
  • SONM 0.06
  • INTS 0.01
  • Stochastic Oscillator
  • SONM 58.23
  • INTS 7.43

About SONM Sonim Technologies Inc.

Sonim Technologies Inc is a provider of ultra-rugged mobile devices, including phones and accessories designed specifically for task workers physically engaged in their work environments, often in mission-critical roles. The company sells mobile phones, accessories, and solutions to AT&T, T-Mobile, and Verizon in the Canada, and to Bell, Rogers, and Telus and Rogers, Telstra in Australia. The products include rugged mobile phones that can attach to both public and private wireless networks, industrial-grade accessories that meet the requirements of specific applications and software applications, and cloud-based tools that provide management and deployment services to customers. The company generates revenue from discounts, price protection, and customer incentives.

About INTS Intensity Therapeutics Inc. Common stock

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.

Share on Social Networks: